Latest Production News

Macarthur Minerals Limited reported a substantial loss of A$25.6 million for the nine months ending December 31, 2024, driven largely by the sale of its Hematite Project. Despite this setback, the company outlines plans for future funding and operational adjustments to sustain its business.

Neometals has received a second tranche of funding from EU-backed EIT RawMaterials, injecting nearly €0.5 million to advance its Finnish Vanadium Recovery Project amid ongoing financing efforts.

Ecofibre Limited has restructured its Australian loan facilities, extending repayment terms and adjusting interest rates to support a more sustainable financial footing.

Forbidden Foods Limited has raised $1 million to boost inventory for its Blue Dinosaur and Oat Milk Goodness brands, following a remarkable 104% jump in quarterly sales.

Asara Resources has raised $2.3 million through a placement led by Barbet L.L.C FZ to advance exploration at its Kada Gold Project in Guinea, coinciding with the appointment of Matthew Sharples as CEO.

Westgold Resources reported a 72% jump in revenue to $624 million in H1 FY25, driven by increased gold production and higher prices, but posted a net loss after tax due to significant one-off acquisition expenses.

BMG Resources is ramping up its drilling efforts at the Abercromby Gold Project with assays from Phase 1 drilling imminent, aiming to expand its existing 518,000oz gold resource. Concurrently, a new drilling program is planned for the nearby Bullabulling Project following a major regional acquisition.

Wellnex Life Limited has locked in A$9 million in conditional commitments to support its proposed dual listing on the London Stock Exchange’s AIM market, alongside launching a 1:1 entitlement offer for existing shareholders.

Artrya Limited has launched a A$15 million capital raising to fund the development and commercial rollout of its Salix AI-powered coronary artery disease diagnostic platform, targeting the lucrative US healthcare market.

Westgold Resources reports a sharp revenue increase driven by higher gold prices and the Karora acquisition, yet posts a net loss for the half-year ending December 2024. The company also declares a fully franked dividend amid rising costs.

Artrya Limited has secured A$15 million through a two-tranche placement aimed at accelerating regulatory approvals and commercial rollout of its Salix® coronary artery disease diagnostic software in the US.

Suvo Strategic Minerals has extended its key take or pay Offtake Agreement with Chaozhou Chengcheng Industrial Co., Ltd, increasing minimum hydrous kaolin order volumes by 25% over five years, valued at approximately A$6.56 million.